Parametric Portfolio Associates’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.13M Sell
392,321
-5,162
-1% -$13.4K ﹤0.01% 2725
2021
Q4
$1.21M Buy
397,483
+140,057
+54% +$608K ﹤0.01% 2705
2021
Q3
$1.8M Buy
257,426
+208,845
+430% +$1.56M ﹤0.01% 2496
2021
Q2
$446K Buy
48,581
+24,493
+102% +$248K ﹤0.01% 3133
2021
Q1
$234K Buy
24,088
+8,432
+54% +$94.2K ﹤0.01% 3814
2020
Q4
$161K Sell
15,656
-40,126
-72% -$406K ﹤0.01% 3825
2020
Q3
$563K Buy
55,782
+9,961
+22% +$101K ﹤0.01% 3212
2020
Q2
$478K Sell
45,821
-25,308
-36% -$262K ﹤0.01% 3296
2020
Q1
$600K Sell
71,129
-119,016
-63% -$1.16M ﹤0.01% 3070
2019
Q4
$1.66M Buy
190,145
+101,334
+114% +$839K ﹤0.01% 2804
2019
Q3
$956K Buy
88,811
+39,916
+82% +$431K ﹤0.01% 3049
2019
Q2
$621K Sell
48,895
-60,174
-55% -$1.39M ﹤0.01% 3276
2019
Q1
$4.23M Buy
109,069
+91,163
+509% +$2.78M ﹤0.01% 2118
2018
Q4
$364K Sell
17,906
-30,223
-63% -$907K ﹤0.01% 3449
2018
Q3
$2.21M Buy
48,129
+6,273
+15% +$302K ﹤0.01% 2648
2018
Q2
$2.48M Buy
41,856
+9,475
+29% +$549K ﹤0.01% 2539
2018
Q1
$2.2M Sell
32,381
-1,893
-6% -$142K ﹤0.01% 2552
2017
Q4
$3.39M Buy
34,274
+19,246
+128% +$2.15M ﹤0.01% 2217
2017
Q3
$1.8M Buy
15,028
+7,184
+92% +$668K ﹤0.01% 2663
2017
Q2
$686K Buy
7,844
+936
+14% +$52.4K ﹤0.01% 3189
2017
Q1
$257K Buy
+6,908
New +$252K ﹤0.01% 3497
2016
Q4
Sell
-14,626
Closed -$981K 3799
2016
Q3
$981K Buy
+14,626
New +$740K ﹤0.01% 2820
2016
Q1
Sell
-5,234
Closed -$410K 4013
2015
Q4
$410K Sell
5,234
-3,592
-41% -$282K ﹤0.01% 3383
2015
Q3
$665K Buy
8,826
+4,424
+100% +$418K ﹤0.01% 2574
2015
Q2
$514K Sell
4,402
-1,249
-22% -$226K ﹤0.01% 3265
2015
Q1
$1.33M Buy
5,651
+1,833
+48% +$392K ﹤0.01% 2558
2014
Q4
$723K Buy
+3,818
New +$847K ﹤0.01% 3029
2014
Q2
Sell
-2,118
Closed -$221K 3778
2014
Q1
$221K Buy
+2,118
New +$249K ﹤0.01% 3581

Other funds holding PBYI